DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Taiwan
  • /
  • Pharmaceuticals & Biotech
Author Program NEWCreate Narrative
3716 logo

Cenra Inc. Stock Price

TWSE:3716 Community·NT$5.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

3716 Share Price Performance

NT$0
-33.70 (-100.00%)
​
NT$0
-33.70 (-100.00%)
​
Price NT$0
Thu, 10 Sep 26
Share Pricen/a

3716 Community Narratives

There are no narratives available yet.
Create Narrative
There are no community narratives available.

Trending Discussion

No trending discussion available.

Recently Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet and good value.

1 Risk
2 Rewards
View Full Analysis

Cenra Inc. Key Details

NT$8.4b

Revenue

NT$5.1b

Cost of Revenue

NT$3.3b

Gross Profit

NT$2.8b

Other Expenses

NT$510.3m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
3.50
39.16%
6.05%
31.1%
View Full Analysis

About 3716

Founded
2024
Employees
n/a
CEO
Hou-Kai Wang
WebsiteView website
www.cenra.com

Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It provides CDMO services for internal and external partners; oral solids, injectables, specialty formulations, and APIs, supported by process development, scale-up, and regulatory support; oral solids, injectables, specialty formulations, and high-purity active pharmaceutical ingredients (APIs), supported by process development, scale-up, and regulatory support; distribution, and marketing for prescription drugs, OTC products, health supplements, personal care products, and medical devices;home care, caregiver training, and consulting for elderly support; develops and manufactures veterinary pharmaceuticals, and animal health products for livestock and companion animals and offers CDMO services for animal health partners. Cenra Inc. was founded in 2024 and is headquartered in Taipei, Taiwan.

Recent 3716 News & Updates

Recent updates

No updates

Cenra Inc. Competitors

6446 logo

PharmaEssentia

Symbol: TWSE:6446
Market cap: NT$557.4b
6696 logo

Lin BioScience

Symbol: TPEX:6696
Market cap: NT$139.3b
6919 logo

Caliway Biopharmaceuticals

Symbol: TWSE:6919
Market cap: NT$128.2b
6949 logo

Pell Bio-Med Technology

Symbol: TWSE:6949
Market cap: NT$71.9b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide